Safety and Pharmacokinetics of LHT344 in Chinese Healthy Subjects
This study has been completed.
Information provided by:
First received: December 21, 2006
Last updated: January 12, 2011
Last verified: January 2011
The purpose of this study is to evaluate safety and pharmacokinetics of a single and multiple dose of LHT344 in 12 Chinese healthy subjects.
This study is not recruiting subjects in the United States.
|Study Design:||Allocation: Non-Randomized
Endpoint Classification: Pharmacokinetics Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
|Official Title:||A Single-center, Open-label, Single and Multiple Oral Dose Study to Assess Safety and Pharmacokinetics of LHT344 in Chinese Healthy Subjects|
Further study details as provided by Novartis:
Primary Outcome Measures:
- Pharmacokinetics of single and repeat daily oral dose of LHT344 in Chinese healthy subjects
Secondary Outcome Measures:
- Safety of single and repeat daily oral dose of LHT344 in Chinese healthy subjects
|Study Start Date:||October 2006|
|Primary Completion Date:||October 2006 (Final data collection date for primary outcome measure)|
Contacts and Locations